Stefania Durando

ORCID: 0000-0002-9986-919X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Genomics and Diagnostics
  • RNA modifications and cancer
  • Cancer Research and Treatments
  • Helicobacter pylori-related gastroenterology studies
  • Molecular Biology Techniques and Applications
  • Genetic factors in colorectal cancer
  • HER2/EGFR in Cancer Research
  • Cancer Cells and Metastasis
  • Colorectal Cancer Treatments and Studies
  • MicroRNA in disease regulation
  • Digestive system and related health
  • Monoclonal and Polyclonal Antibodies Research
  • Cytokine Signaling Pathways and Interactions
  • Viral-associated cancers and disorders
  • Nanoplatforms for cancer theranostics
  • Cancer, Stress, Anesthesia, and Immune Response
  • Lymphoma Diagnosis and Treatment
  • Immune Cell Function and Interaction

Candiolo Cancer Institute
2017-2023

Istituti di Ricovero e Cura a Carattere Scientifico
2017-2018

Abstract Gastric cancer is the world's third leading cause of mortality. In spite significant therapeutic improvements, clinical outcome for patients with advanced gastric poor; thus, identification and validation novel targets extremely important from a point view. We generated wide, multilevel platform models, comprising 100 patient-derived xenografts (PDX), primary cell lines, organoids. Samples were classified according to their histology, microsatellite stability, Epstein–Barr virus...

10.1158/0008-5472.can-19-1166 article EN Cancer Research 2019-10-04

Patient-Derived Xenografts (PDXs), entailing implantation of cancer specimens in immunocompromised mice, are emerging as a valuable translational model that could help validate biologically relevant targets and assist the clinical development novel therapeutic strategies for gastric cancer. More than 30% PDXs generated from carcinoma samples developed human B-cell lymphomas instead These were monoclonal, Epstein Barr Virus (EBV) positive, originated tumorigenic cell cultures displayed...

10.1016/j.neo.2018.02.003 article EN cc-by-nc-nd Neoplasia 2018-03-23

<div>Abstract<p>Gastric cancer is the world's third leading cause of mortality. In spite significant therapeutic improvements, clinical outcome for patients with advanced gastric poor; thus, identification and validation novel targets extremely important from a point view. We generated wide, multilevel platform models, comprising 100 patient-derived xenografts (PDX), primary cell lines, organoids. Samples were classified according to their histology, microsatellite stability,...

10.1158/0008-5472.c.6511170 preprint EN 2023-03-31

<div>Abstract<p>Gastric cancer is the world's third leading cause of mortality. In spite significant therapeutic improvements, clinical outcome for patients with advanced gastric poor; thus, identification and validation novel targets extremely important from a point view. We generated wide, multilevel platform models, comprising 100 patient-derived xenografts (PDX), primary cell lines, organoids. Samples were classified according to their histology, microsatellite stability,...

10.1158/0008-5472.c.6511170.v1 preprint EN 2023-03-31
Coming Soon ...